Functional cloning of ARM-1, an adhesion-regulating molecule upregulated in metastatic tumor cells

Clinical and Experimental Metastasis

Volumn 17, Issue 8, 1999, Pages 641-648

  Simins, Almut B ^a   Weighardt, Heike ^a   Weidner, K Michael ^b   Weidle, Ulrich H ^b   Holzmann, Bernhard ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Adhesion molecules; Cell adhesion; Endothelium; Tumor metastasis

Indexed keywords

BETA1 INTEGRIN; CELL ADHESION MOLECULE; CELL RECEPTOR; COMPLEMENTARY DNA; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN ARM 1; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER GROWTH; CELL ADHESION; CONTROLLED STUDY; DNA SEQUENCE; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; RECEPTOR UPREGULATION; STROMA; T CELL LYMPHOMA;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE; CLONING, MOLECULAR; DNA, NEOPLASM; ENDOTHELIUM; HUMANS; INTEGRINS; KIDNEY; LYMPHOMA, T-CELL; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033361178     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006790912877     Document Type: Article

References (38)

1. 1. Ebnet K, Kaldjian EP, Anderson AO et al. Orchestrated information transfer underlying leukocyte endothelial interactions. Annu Rev Immunol 1996; 14: 155-77.
2. 2. Rossiter H, Alon R, Kupper TS. Selectins, T-cell rolling and inflammation. Mol Med Today 1997; 3: 214-22.
3. 3. Öbrink B. CEA adhesion molecules: multifunctional proteins with signal-regulatory properties. Curr Opin Cell Biol 1997; 9: 616-26.
4. 4. Gendler SJ, Spicer AP. Epithelial mucin genes. Annu Rev Physiol 1995; 57: 607-34.
5. 5. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994; 1198: 11-26.
6. 6. Kincade PW, Zheng Z, Katoh S et al. The importance of cellular environment to function of the CD44 matrix receptor. Curr Opin Cell Biol 1997; 9: 635-42.
7. 7. Varner JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol 1996; 8: 724-30.
8. 8. Guilford P, Hopkins J, Harraway J et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402-5.
9. 9. Perl A-K, Wilgenbus P, Dahl U et al. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 190-3.
10. 10. Nakamori S, Ota DM, Cleary KR et al. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 1994; 106: 353-61.
11. 11. Ho SB, Niehans GA, Lyftogt C et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993; 53: 641-651.
12. 12. Hanski C, Drechsler K, Hanisch FG et al. Altered glycosylation of the MUC-1 protein core contributes to the colon carcinoma-associated increase of mucin-bound sialyl-Lewis(x) expression. Cancer Res 1993; 53: 4082-8.
13. 1-integrin expression: contributions to epithelial cell differentiation and the malignant phenotype. Cancer Res 1998; 167-85.
14. 14. Zutter MM, Santoro SA, Staatz WD et al. Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA 1995; 92: 7411-5.
15. 15. Zutter MM, Krigman HR, Santoro SA. Altered integrin expression in adenocarcinoma of the breast. Analysis by in situ hybridization. Am J Pathol 1993; 142: 1439-48.
16. 16. Qian F, Vaux DL, Weissman IL. Expression of the integrin α4β1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 1994; 77: 335-47.
17. 17. Holzmann B, Gosslar U, Bittner M. α4-Integrins and tumor metastasis. Curr Topics Microbiol Immunol 1998; 231: 125-41.
18. 18. Gosslar U, Jonas P, Luz A et al. Predominant role of α4-integrins for distinct steps of lymphoma metastasis. Proc Natl Acad Sci USA 1996; 93: 4821-6.
19. 2-Integrin dependent aggregate formation between LB T cell lymphoma and spleen cells: Assessment of correlation with spleen invasiveness. Int Immunol 1994; 6: 917-24.
20. 20. Zahalka MA, Okon E, Naor D. Blocking lymphoma invasiveness with a monoclonal antibody directed against the β-chain of the leukocyte adhesion molecule (CD18). J Immunol 1993; 150: 4466-77.
21. 21. Lugasi H, Hajos S, Murphy JR et al. Murine spontaneous T-cell leukemia constitutively expressing IL-2 receptor-a model for human T-cell malignancies expressing IL-2 receptor. Int J Cancer 1990; 45: 163-7.
22. 4-integrin-dependent cytokine-induced adhesion. Exp Cell Res 1991; 197: 259-67.
23. 23. Schiemann S, Schwirzke M, Brunner N et al. Molecular analysis of two mammary carcinoma cell lines at the transcriptional level as a model system for progression of breast cancer. Clin Exp Metastasis 1998; 16: 129-39.
24. 24. Schwirzke M, Gnirke A, Bork P et al. Differential gene expression in mammary carcinoma cell lines: Identification of DRIM, a new gene down-regulated in metastasis. Anticancer Res 1998; 18: 1409-21.
25. 25. Fairchild CR, Ivy SP, Kao-Shan C-S et al. Isolation of amplified and overexpressed DNA sequences from adriamycinresistant human breast cancer cells. Cancer Res 1987; 47: 5141-8.
26. 26. Brinkley BR, Beall PT, Wible LJ et al. Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro. Cancer Res 1980; 40: 3118-29.
27. 27. Rietzler M, Bittner M, Kolanus W et al. The human WD repeat protein WAIT-1 specifically interacts with the cytoplasmic tails of β7-integrins. J Biol Chem 1998; 273: 27459-66.
28. 28. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 2745-50.
29. 29. Altschul SF, Madden TL, Schäffer AA et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 1997; 25: 3389-402.
30. 30. Chirgwin JM, Przybyla AE, MacDonald RJ et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-9.
31. 31. Naor D, Sionov RV, Zahalka M et al. Organ-specific requirements for cell adhesion molecules during lymphoma cell dissemination. Curr Topics Microbiol Immunol 1998; 231: 143-66.
32. 32. Zahalka MA, Okon E, Gosslar U et al. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J Immunol 1995; 154: 5345-55.
33. 33. Nielsen H, Engelbrecht J, Brunak S et al. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Engineering 1997; 10: 1-6.
34. 34. Hansen JE, Lund O, Rapacki K et al. O-glycbase version 2.0 - a revised database of O-glycosylated proteins. Nucleic Acids Res 1997; 25: 278-82.
35. 35. Hansen JE, Lund O, Tolstrup N et al. NetOglyc: Prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility. Glycoconjugate J 1998; 15: 115-30.
36. r 110,000 gene product in human gastric carcinoma cells that is immunologically related to carcinoembryonic antigen. Cancer Res 1991; 51: 5694-703.
37. r 110,000 antigen expressed by human gastric cells and upregulated by γ-inteferon. Cancer Res 1994; 54: 3831-6.
38. 38. Sutherlin ME, Nishimori I, Caffrey T et al. Expression of three UDP-N-acetyl-α-D-galactosamine:polypeptide GalNAc N-acetyl-agalactosaminyltransferases in adenocarcinoma cell lines. Cancer Res 1997; 57: 4744-8.